{
    "name": "spesolimab",
    "comment": "Rx",
    "other_names": [
        "Spevigo",
        "spesolimab-sbzo"
    ],
    "classes": [
        "Interleukin Inhibitors"
    ],
    "source": "https://reference.medscape.com/drug/spevigo-spesolimab-4000271",
    "pregnancy": {
        "common": [
            "Data regarding use pregnant females are insufficient to inform a drug-associated risk of adverse pregnancy-related outcomes",
            "Human IgG crosses the placental barrier; therefore, spesolimab may be transmitted from mother to developing fetus"
        ],
        "specific": [
            {
                "type": "Animal studies ",
                "description": [
                    "IV administration of a surrogate antibody against IL36R in mice during organogenesis did not elicit any reproductive toxicity"
                ]
            }
        ]
    },
    "lactation": {
        "common": []
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "axicabtagene ciloleucel",
            "description": {
                "common": "spesolimab, axicabtagene ciloleucel.\nEither increases effects of the other by immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "brexucabtagene autoleucel",
            "description": {
                "common": "spesolimab, brexucabtagene autoleucel.\nEither increases effects of the other by immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "ciltacabtagene autoleucel",
            "description": {
                "common": "spesolimab, ciltacabtagene autoleucel.\nEither increases effects of the other by immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "idecabtagene vicleucel",
            "description": {
                "common": "spesolimab, idecabtagene vicleucel.\nEither increases effects of the other by immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "lisocabtagene maraleucel",
            "description": {
                "common": "spesolimab, lisocabtagene maraleucel.\nEither increases effects of the other by immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "tisagenlecleucel",
            "description": {
                "common": "spesolimab, tisagenlecleucel.\nEither increases effects of the other by immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Asthenia and fatigue",
            "percent": "9"
        },
        {
            "name": "Nausea and vomiting",
            "percent": "9"
        },
        {
            "name": "Headache",
            "percent": "9"
        },
        {
            "name": "Pruritus and prurigo",
            "percent": "6"
        },
        {
            "name": "Infusion",
            "percent": "6"
        },
        {
            "name": "site hematoma and bruising",
            "percent": "6"
        },
        {
            "name": "Urinary tract infection",
            "percent": "3"
        },
        {
            "name": "Bacteremia",
            "percent": "3"
        },
        {
            "name": "Bacteriuria",
            "percent": "3"
        },
        {
            "name": "Cellulitis",
            "percent": "3"
        },
        {
            "name": "Herpes dermatitis and oral herpes",
            "percent": "3"
        },
        {
            "name": "Upper respiratory tract infection",
            "percent": "3"
        },
        {
            "name": "Dyspnea",
            "percent": "3"
        },
        {
            "name": "Eye edema",
            "percent": "3"
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "Drug reaction with eosinophilia and systemic symptoms",
            "percent": null
        },
        {
            "name": "DRESS",
            "percent": null
        },
        {
            "name": "Injection site erythema",
            "percent": null
        },
        {
            "name": "swelling",
            "percent": null
        },
        {
            "name": "pain",
            "percent": null
        },
        {
            "name": "induration",
            "percent": null
        },
        {
            "name": "and warmth",
            "percent": null
        }
    ]
}